Digital Asset Treasury Management / Cryptocurrency (formerly Biotechnology)
Strategic Profile
The new ticker BNBX reflects the company's stated shift to a BNB-based digital asset treasury strategy focused on yield generation and token accumulation within the Binance ecosystem, pursuing an actively managed approach that integrates decentralized finance protocols and Binance-specific strategies. The company authorized a comprehensive corporate restructuring that includes a 60% workforce reduction (16 employees) and is expected to yield substantial annualized cost savings of approximately $2.9 million.
Cyborg Score Rationale
Applied DNA executed a dramatic pivot from established biotech operations to cryptocurrency treasury management, dramatically reducing workforce and operational capacity. The strategic shift introduces significant execution risk and represents a departure from core competencies, though the company secured $27 million in capital commitments for the new strategy.
Top Insights
Radical strategic pivot to crypto treasury management with BNB focus, abandoning traditional biotech business model
60% workforce reduction completed by October 2025, signaling major operational downsizing and cost restructuring
Secured $27 million in private placement commitments for BNB digital asset strategy with potential $31 million additional capital
Company changed ticker to BNBX in October 2025 and formally renamed to BNB Plus Corp. in November 2025, reflecting complete business reorientation
Named Competitors
Ginkgo Bioworks — Synthetic biology and DNA engineering (former competitor in biotech space)
Zymergen — Biomanufacturing for biotechnology (former competitor in biotech space)
Recent Developments
(November 2025) Company renamed to BNB Plus Corp.
(October 2025) Ticker symbol changed from APDN to BNBX; 60% workforce reduction completed
(October 2025) $27 million private placement completed for BNB digital asset treasury strategy with potential additional $31 million from warrant exercises
Open the full interactive Applied DNA Sciences, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.